References:
  1. Puetz J, Cheng D. Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdataset. Haemophilia.2021;27(6):1045-1050.
  2. Paroskie A, Gailani D, DeBaun MR, Sidonio RF Jr. A cross-sectional study of bleeding phenotype in haemophilia A carriers. Br J Haematol. 2015;170(2):223-8.
  3. Plug I, Mauser-Bunschoten EP, Brocker-Vriends AH et al. Bleeding in carriers of hemophilia. Blood . 2006;108(1):52-6
  4. Van Galen K, d’Oiron R, James P et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost.2021;19(8):1883-188.
  5. Elbatarny M, Mollah S, Grabell J et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831-5.
  6. Doherty D, Grabell J, Christopherson P et al. Variability in International Society on Thrombosis and Haemostasis=Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females:contributory factors and clinical significance. J Thromb Haemost 2023:21:880-886.
  7. Jain S, Zhang S, Acosta M, Malone K, Kouides P, Zia A. Prospective evaluation of ISTH-BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic. J Thromb Haemost2020;18(10):2542-2550.
  8. Biguzzi E, Castelli F, Lijfering W et al. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors. Thromb Res 2021;197:172-178.
  9. Appel I, Grimminck B,GeertsJ et al. Age dependency of coagulation parameters during childhood and puberty. J Thromb Haemost 2012; 10:2254-2263.
  10. Puetz J, Johnson L, Hugge C, Buchanan P. First Look at My Life, Our Future Carrier Data from a Pilot Site. Res Pract Thromb Haemost. 2018;2(S1):60.
  11. Young JE, Grabell J, Tuttle A et al. Evaluation of the self-administered bleeding assessment tool (Self-BAT) in haemophilia carriers and correlations with quality of life. Haemophilia.2017;23(6):e536-e8.
  12. Li S, Fang Y, Li L et al. Bleeding assessment in haemophilia carriers-High rates of bleeding after surgical abortion and intrauterine device placement: A multicentre study in China.Haemophilia. 2020;26(1):122-8.
  13. Baud’huin M, Duplomb L, Teletchea S et al. Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival.J Biol Chem 2009;284(46)31704-31713.
  14. Citla-Sridhar D, Sidonio R, Ahuja S. Bone health in haemophilia carriers and persons with von Willebrand disease: A large database analysis. Haemophilia 2022;28(4):671-678.
  15. Saes J, Verhagen M, Meijer K et al. Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study.Blood Adv 2020;4(20):5025-5034.
  16. Puetz J, Hugge C, Moser K. Normal aPTT in children with factor XI deficiency. Pediatr Blood Cancer 2018;65(4):e26910
  17. Wheeler A, Gailani D. Why factor XI deficiency is a clinical concern.Expert Rev Hematol 2016;9(7):629-637.
  18. Peyvandi F, Palla R, Menegatti M et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012;10(4):615-621.
  19. Den Uijl I, Bunschoten E, Roosendaal G et al. Clinical severity of haemophilia A: does the classification of the 1950s still stand?Haemophia 2011;17(6):849-853.
  20. Borry P, Fryns J, Schotsmans P, Dierickx K. Carrier testing in minors: a systematic review of guidelines and position papers. Eur J Hum Genet 2005;14(2):133-138.
  21. Committee on Bioethics, Committee on Genetics, and The American College of Medical Genetics and Genomics Social, Ethical and Legal Issues Committee. Ethical and Policy Issues in Genetic Testing and Screening of Children.Pediatrics 2013;131(3):620-622.
  22. Vears D, Metcalfe S. Carrier testing in children and adolescents.Eur J Hum Genet 2015;58(12):659-667.
  23. James PD, Mahlangu J, Bidlingmaier C et al. Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study.Haemophilia. 2016;22(6):912-8.
  24. Tosetto A, Rodeghiero F, Castaman G et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost.2006;4(4):766-73.
  25. Olsson A, Hellgren M, Berntorp E, Ljung R, Baghaei F. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B. Blood Coagul Fibrin. 2014;25(5):471-5.
  26. Miesbach W, Alesci S, Geisen C, Oldenburg J. Association between phenotype and genotype in carriers of haemophilia A.Haemophilia 2011;17(2):246-251.